|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Recondo G, Facchinetti F, Olaussen KA,
Besse B and Friboulet L: Making the first move in EGFR-driven or
ALK-driven NSCLC: First-generation or next-generation TKI? Nat Rev
Clin Oncol. 15:694–708. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pacheco JM, Gao D, Smith D, Purcell T,
Hancock M, Bunn P, Robin T, Liu A, Karam S, Gaspar L, et al:
Natural History and Factors Associated with Overall Survival in
Stage IV ALK-Rearranged Non-small cell lung cancer. J Thorac Oncol.
14:691–700. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shokoohi A, Al-Hashami Z, Moore S, Pender
A, Wong SK, Wang Y, Leung B, Wu J and Ho C: Effect of targeted
therapy and immunotherapy on advanced nonsmall-cell lung cancer
outcomes in the real world. Cancer Med. 11:86–93. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cameron LB, Hitchen N, Chandran E, Morris
T, Manser R, Solomon BJ and Jordan V: Targeted therapy for advanced
anaplastic lymphoma kinase (ALK)-rearranged non-small cell
lung cancer. Cochrane Database Syst Rev. 1:CD0134532022.PubMed/NCBI
|
|
6
|
Bittner N, Ostoros G and Geczi L: New
treatment options for lung adenocarcinoma-in view of molecular
background. Pathol Oncol Res. 20:11–25. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nishio M, Nakagawa K, Mitsudomi T,
Yamamoto N, Tanaka T, Kuriki H, Zeaiter A and Tamura T: Analysis of
central nervous system efficacy in the J-ALEX study of alectinib
versus crizotinib in ALK-positive non-small-cell lung cancer. Lung
Cancer. 121:37–40. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Larkins E, Blumenthal GM, Chen H, He K,
Agarwal R, Gieser G, Stephens O, Zahalka E, Ringgold K, Helms W, et
al: FDA approval: Alectinib for the treatment of metastatic,
ALK-positive non-small cell lung cancer following crizotinib. Clin
Cancer Res. 22:5171–5176. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Paik J and Dhillon S: Alectinib: A review
in advanced, ALK-Positive NSCLC. Drugs. 78:1247–1257. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dagogo-Jack I, Gainor JF, Porter RL,
Schultz KR, Solomon BJ, Stevens S, Azzoli CG, Sequist LV, Lennes IT
and Shaw AT: Clinicopathologic features of NSCLC diagnosed during
pregnancy or the peripartum period in the era of molecular
genotyping. J Thorac Oncol. 11:1522–1528. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Boussios S, Han SN, Fruscio R, Halaska MJ,
Ottevanger PB, Peccatori FA, Koubková L, Pavlidis N and Amant F:
Lung cancer in pregnancy: Report of nine cases from an
international collaborative study. Lung Cancer. 82:499–505. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pavlidis N: Lung cancer during pregnancy:
An emerging issue. Lung Cancer. 59:279–281. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Van Calsteren K, Heyns L, De Smet F, Van
Eycken L, Gziri MM, Van Gemert W, Halaska M, Vergote I, Ottevanger
N and Amant F: Cancer during pregnancy: An analysis of 215 patients
emphasizing the obstetrical and the neonatal outcomes. J Clin
Oncol. 28:683–689. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Moran BJ, Yano H, Al Zahir N and
Farquharson M: Conflicting priorities in surgical intervention for
cancer in pregnancy. Lancet Oncol. 8:536–544. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cardonick E and Iacobucci A: Use of
chemotherapy during human pregnancy. Lancet Oncol. 5:283–291. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Amant F, Van Calsteren K, Halaska MJ,
Gziri MM, Hui W, Lagae L, Willemsen MA, Kapusta L, Van Calster B,
Wouters H, et al: Long-term cognitive and cardiac outcomes after
prenatal exposure to chemotherapy in children aged 18 months or
older: An observational study. Lancet Oncol. 13:256–264. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
de Haan J, Verheecke M, Van Calsteren K,
Van Calster B, Shmakov RG, Mhallem Gziri M, Halaska MJ, Fruscio R,
Lok CAR, Boere IA, et al: Oncological management and obstetric and
neonatal outcomes for women diagnosed with cancer during pregnancy:
A 20-year international cohort study of 1170 patients. Lancet
Oncol. 19:337–346. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Stovall M, Blackwell CR, Cundiff J, Novack
DH, Palta JR, Wagner LK, Webster EW and Shalek RJ: Fetal dose from
radiotherapy with photon beams: Report of AAPM Radiation Therapy
Committee Task Group No. 36. Med Phys. 22:63–82. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Borgers JSW, Heimovaara JH, Cardonick E,
Dierickx D, Lambertini M, Haanen JBAG and Amant F: Immunotherapy
for cancer treatment during pregnancy. Lancet Oncol. 22:e550–e561.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Amant F, Han SN, Gziri MM, Vandenbroucke
T, Verheecke M and Van Calsteren K: Management of cancer in
pregnancy. Best Pract Res Clin Obstet Gynaecol. 29:741–753. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Acosta Rojas A, Collazo-Lorduy A, Remon J,
Hernando Requejo O, Jiménez-Munarriz B, Rubio Rodríguez MC and De
Castro J: Lung Adenocarcinoma during Pregnancy: 11-Year Follow-Up.
Case Rep Oncol. 13:892–895. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Komura M, Yagishita S, Nakamura K, Arano
N, Takeshige T, Muraki K, Nagashima O, Izumi H, Tomita S, Sasaki S
and Takahashi K: A case of a pregnant woman diagnosed as having
ALK-rearranged lung adenocarcinoma. In Vivo. 32:1205–1209. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Neves I, Mota PC and Hespanhol VP: Lung
cancer during pregnancy: An unusual case. Rev Port Pneumol.
20:46–49. 2014.(In English, Portuguese). View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sariman N, Levent E, Yener NA, Orki A and
Saygi A: Lung cancer and pregnancy. Lung Cancer. 79:321–323. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Peccatori FA, Azim HA Jr, Orecchia R,
Hoekstra HJ, Pavlidis N, Kesic V and Pentheroudakis G; ESMO
Guidelines Working Group, : Cancer, pregnancy and fertility: ESMO
Clinical Practice Guidelines for diagnosis, treatment and
follow-up. Ann Oncol. 24 (Suppl 6):vi160–vi170. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Webb TR, Slavish J, George RE, Look AT,
Xue L, Jiang Q, Cui X, Rentrop WB and Morris SW: Anaplastic
lymphoma kinase: Role in cancer pathogenesis and small-molecule
inhibitor development for therapy. Expert Rev Anticancer Ther.
9:331–356. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Scarfone G, Fumagalli M, Imbimbo M, Ceruti
T, Cribiù FM, Di Loreto E, D'Incalci M, Facchin F, Fontana C,
Garassino MC, et al: First case report of pregnancy on alectinib in
a woman with metastatic ALK-Rearranged lung cancer: A case report.
J Thorac Oncol. 16:873–877. 2021. View Article : Google Scholar : PubMed/NCBI
|
